NA and EU Stroke Diagnostics Market Worth $1.4 Billion by 2024: Grand View Research, Inc.

SAN FRANCISCO, July 25, 2016 /PRNewswire/ —

The North America and Europe stroke diagnostics market is expected to reach USD 1.4 million by 2024, according to a new report by Grand View Research Inc. The stroke diagnostics market is anticipated to witness a lucrative growth during the period of 2016 to 2024. An approximate of 795,000 people suffer from a stroke annually in the U.S., costing the nation around USD 34 billion. Stroke being the significant cause of morbidity and mortality, the government is taking initiatives to counter stroke and its incidence.

     (Logo: )

For instance, smoking being recognized as a primary cause of stroke, the U.S. government has taken several measures for smoking cessation. Some of these initiatives include the Family Smoking Prevention and Tobacco Control Act, which grant the FDA power to control the production, marketing, and use of tobacco products.

The key factors attributing to the growth of the industry are the advancing age of the population, increasing adoption of unhealthy lifestyle, and growing awareness about the disease among the people. However, the decline in the stroke incidence rates is expected to restrict the growth of the market to an extent.

On the basis of technology, the stroke diagnostics market is fragmented into Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), carotid ultrasound, cerebral angiography, nuclear imaging, and others. The key countries considered in the study are the U.S., Canada, Germany, the U.K., France, Italy, and Spain.

Browse full research report with TOC on North America And Europe Stroke Diagnostics Market Analysis By Technology (Magnetic Resonance Imaging (MRI), Computed Tomography Scan (CT Scan), Carotid Ultrasound, Cerebral Angiography, and Nuclear Imaging), By Region (U.S., Canada, France, Germany, Italy, Spain, and UK) And Segment Forecasts To 2024 at:

Further key findings from the study suggest: 

Request for sample of this research report:

Grand View Research has segmented the North America and Europe stroke diagnostics market on the basis of technology and region: 

Browse related reports by Grand View Research: 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs,

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519


Most Popular

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2015 A Daily News.

To Top